CTX-130
CRISPR Therapeutics AG
['car-t']
$crsp ph1 ctx130 (cd70 allo car-t) topline of '70% orr and 30% cr rate' neatly neglects the fact that the mdor seems to be ~1.9 months #eha2022 
L/S biotech. PhD student @UniofOxford